Search results
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1...
Benzinga· 4 days agoWith the earnings season now halfway through, the percentage of S&P 500 companies reporting positive...
Zacks Industry Outlook Highlights Descartes Systems Group, Blackbaud and BlackBerry
Zacks via Yahoo Finance· 3 days agoAids Prospects: The industry’s prospects are bright, given higher spending by enterprises on...
Shiba Inu and Pepecoin price speculation lets off bullish signals: Is O2T next?
CryptoNewsZ.com· 1 day agoOption2Trade (O2T), an AI-driven trading platform, is poised to join the ranks of successful meme...
3 Software Stocks to Keep an Eye on in a Troubled Industry
Zacks via Yahoo Finance· 3 days agoAmid volatile macroeconomic conditions, Computer Software industry participants like Descartes...
Leaders Can Use 5 Strategies To Understand Consumer Trends In Society
Forbes· 2 days agoAs an example of these complex consumption dynamics, consider the current behavior of Chinese...
Lindbrook Capital LLC Increases Holdings in AppLovin Co. (NASDAQ:APP)
ETF DAILY NEWS· 7 days agoLindbrook Capital LLC grew its holdings in shares of AppLovin Co. (NASDAQ:APP – Free Report) by...
Tuesday's analyst calls: Nvidia to get a boost from new chip, Ralph Lauren poised to jump
CNBC· 3 days agoPlease refresh every 20-30 minutes to view the latest posts.) Tuesday's analyst calls focused on...
Universal Music and TikTok strike new licensing deal - Music Business Worldwide
Music Business Worldwide· 17 hours agoUniversal Music Group and TikTok have struck what they call “a new multi-dimensional licensing agreement”. According to a joint press release issued today (May 2), the deal “will deliver significant ...
Canaccord Genuity Group Cuts Guardant Health (NASDAQ:GH) Price Target to $30.00
ETF DAILY NEWS· 2 days agoGuardant Health (NASDAQ:GH – Get Free Report) had its price objective lowered by stock analysts at Canaccord Genuity Group from $45.00 to $30.00 in a report issued on Monday, Benzinga reports ...
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
AOL· 3 days agoJust a few short years after coming to market, the latest GLP-1 drugs are showing versatility in battling diseases related to diabetes and obesity, lifting the fortunes and expectations for ...